GP Flashcards

1
Q

What would you cover in a standard T2 diabetes checkup?

A

Blood glucose testing: This is one of the most important tests for people with type 2 diabetes. The doctor will check the patient’s blood glucose levels to see how well their diabetes is being managed.

HbA1C testing: This is a blood test that measures a person’s average blood glucose level over the past 2-3 months. It provides an overall picture of how well their diabetes is being managed.

Blood pressure testing: High blood pressure is a common complication of diabetes. The doctor will check the patient’s blood pressure to see if it is within a healthy range.

Cholesterol testing: Diabetes can increase the risk of heart disease and stroke, so it is important to check cholesterol levels.

Kidney function testing: Diabetes can damage the kidneys over time. The doctor will check the patient’s kidney function with a blood and urine test.

Foot exam: Diabetes can cause nerve damage in the feet, so the doctor will check for any signs of foot problems.

Eye exam: Diabetes can damage the eyes over time, so the doctor will check for any signs of eye problems.

Diet and exercise counseling: A healthy diet and regular exercise are important for managing type 2 diabetes. The doctor may offer counseling on how to make lifestyle changes to improve diabetes management.

Medication adjustments: Depending on the results of the tests, the doctor may adjust the patient’s medication regimen to help better manage their diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the RACGP guidelines for safe alcohol drinking?​

A

2 standard drinks or less per day, no more than four on any one occasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some recommended preventative activities for infants and young children, as outlined in the RACGP Red Book?

A

The RACGP Red Book recommends preventative activities for infants and young children such as exclusive breastfeeding for the first 6 months, vitamin D supplementation for breastfed infants, and avoidance of exposure to tobacco smoke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How often should a child’s height and weight be measured during the first 2 years of life, according to the Red Book?

A

The RACGP Red Book recommends measuring a child’s height and weight at every visit in the first 2 years of life, and then annually thereafter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the recommended age range for routine screening for vision and hearing in children, according to the Red Book?

A

The recommended age range for routine screening for vision and hearing in children is between 4-5 years of age, according to the RACGP Red Book.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some recommended preventative activities for school-aged children, as outlined in the RACGP Red Book?

A

The RACGP Red Book recommends preventative activities for school-aged children such as encouraging physical activity, healthy eating habits, and promoting sun protection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the recommended schedule for immunisations in children, according to the Red Book?

A

The RACGP Red Book provides a recommended schedule for immunisations in children, which includes vaccinations for diseases such as measles, mumps, rubella, pertussis, and hepatitis B, among others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the recommended age range for screening for dyslipidaemia in children and adolescents, as outlined in the Red Book?

A

The RACGP Red Book recommends screening for dyslipidaemia in children and adolescents between the ages of 9-11 years, and again between the ages of 18-21 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the recommended age for administering the first dose of the hepatitis B vaccine to infants in Australia?

A

The first dose of the hepatitis B vaccine is recommended to be given within 24 hours of birth, as per the Australian National Immunisation Program (NIP) schedule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many doses of the diphtheria-tetanus-pertussis vaccine (DTaP) are recommended for children in the Australian National Immunisation Program schedule?

A

The NIP schedule recommends five doses of DTaP vaccine to be given at 2, 4, 6, 18 months, and 4 years of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

At what age should children receive the first dose of the pneumococcal vaccine in Australia?

A

The first dose of the pneumococcal vaccine is recommended to be given at 6 weeks of age, as per the NIP schedule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the recommended age for administering the first dose of the measles-mumps-rubella (MMR) vaccine in Australia?

A

The first dose of the MMR vaccine is recommended to be given at 12 months of age, as per the NIP schedule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What vaccine is recommended for all infants in Australia at 6 weeks of age?

A

The first dose of the combined diphtheria-tetanus-acellular pertussis-inactivated polio-Haemophilus influenzae type b vaccine (DTPa-IPV-Hib) is recommended for all infants in Australia at 6 weeks of age.

As well as the 1st rotavirus and pneumococcal vaccine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many doses of the rotavirus vaccine are recommended for infants in Australia?

A

The NIP schedule recommends two doses of the rotavirus vaccine to be given at 6 weeks and 4 months of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the recommended age for administering the human papillomavirus (HPV) vaccine in Australia?

A

The HPV vaccine is recommended to be given at 12-13 years of age, as per the NIP schedule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What vaccine is recommended for all children in Australia at 12 months of age?

A

The NIP schedule recommends the measles-mumps-rubella (MMR) vaccine be given at 12 months of age. As well as the first dose of the meningococcal ACWY and pneumococcal vaccine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How many doses of the meningococcal ACWY vaccine are recommended for adolescents in Australia?

A

The NIP schedule recommends one dose of the meningococcal ACWY vaccine for adolescents at 12 months of age and a booster dose at 15 years of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the recommended age for administering the varicella (chickenpox) vaccine in Australia?

A

The varicella vaccine is recommended to be given at 18 months of age, as per the NIP schedule, as a part of the MMRV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What vaccine is recommended for all children in Australia at 4 years of age?

A

The NIP schedule recommends the diphtheria-tetanus-pertussis vaccine (DTaP) and inactivated polio vaccine (IPV) booster to be given at 4 years of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the recommended frequency for colorectal cancer screening in middle-aged adults with average risk?

A

For average-risk adults aged 50-74 years, the RACGP recommends screening for colorectal cancer every two years with fecal occult blood testing (FOBT), or every 10 years with colonoscopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the recommended screening tests for cervical cancer in middle-aged women with no history of abnormal results?

A

The RACGP recommends that women aged 25-74 years undergo screening for cervical cancer every five years with a human papillomavirus (HPV) test.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the recommended guidelines for blood pressure screening in middle-aged adults?

A

The RACGP recommends that all adults aged 45 years and older have their blood pressure checked at least once a year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the recommended guidelines for lipid screening in middle-aged adults?

A

The RACGP recommends that all adults aged 45-49 years have their lipids checked at least once, and those aged 50-74 years have their lipids checked every five years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the recommended guidelines for diabetes screening in middle-aged adults with no history of diabetes?

A

The RACGP recommends that all adults aged 40-49 years have a diabetes risk assessment at least once, and those aged 50-74 years have their blood glucose levels checked every three years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the recommended guidelines for osteoporosis screening in middle-aged adults?

A

Review fracture risk factors for women aged >45 years and men aged >50 years.

The RACGP recommends that women aged 50-69 years and men aged 70-74 years have a bone mineral density test at least once.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the recommended guidelines for skin cancer screening in middle-aged adults?

A

The RACGP recommends that all adults perform monthly self-examination for skin cancer and visit a healthcare professional for a full-body skin examination at least every two years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the recommended guidelines for breast cancer screening in middle-aged women?

A

The RACGP recommends that women aged 50-74 years have a mammogram every two years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the recommended guidelines for prostate cancer screening in middle-aged men?

A

The RACGP recommends that men aged 50-69 years make an informed decision about prostate cancer screening after discussing the benefits and harms with their healthcare provider.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the recommended guidelines for immunizations in middle-aged adults?

A

The RACGP recommends that middle-aged adults receive recommended immunizations, including influenza vaccine every year, pneumococcal vaccine if indicated, and tetanus-diphtheria-pertussis vaccine every 10 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the recommended vaccinations for adults aged 65 years and older?

A

The recommended vaccination schedule for older adults in Australia includes a yearly influenza vaccine, a one-time dose of pneumococcal vaccine (if not previously vaccinated), and a shingles vaccine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the recommended interval between two doses of shingles vaccine?

A

Answer: The recommended interval between two doses of the shingles vaccine is two to six months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the recommended interval between the pneumococcal vaccine and the previous dose or doses?

A

Answer: The recommended interval between the pneumococcal vaccine and any previous dose or doses is at least five years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Can older adults receive the shingles vaccine if they have had shingles before?

A

Yes, older adults can receive the shingles vaccine even if they have had shingles before, as the vaccine can help prevent future episodes or reduce the severity of symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Differences between Shingrix and Zostavax.

A

How do Shingrix and Zostavax differ in their composition?
Answer: Shingrix is a recombinant zoster vaccine that contains a piece of the herpes zoster virus, while Zostavax is a live attenuated vaccine that contains a weakened form of the virus.

Which vaccine is more effective in preventing shingles?
Answer: Shingrix is more effective in preventing shingles compared to Zostavax, with an efficacy rate of over 90% compared to about 50% for Zostavax.

How many doses of Shingrix are required and what is the interval between doses?
Answer: Shingrix requires two doses, with an interval of 2 to 6 months between doses.

How many doses of Zostavax are required and what is the interval between doses?
Answer: Zostavax requires one dose only.

Who can receive Shingrix?
Answer: Shingrix is recommended for adults aged 50 years and older, including those who have previously received Zostavax.

Who can receive Zostavax?
Answer: Zostavax is recommended for adults aged 60 years and older who have not received the shingles vaccine before.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are some risk factors for falls in older adults?

A

Some risk factors for falls in older adults include history of falls, muscle weakness, gait and balance disorders, visual impairment, cognitive impairment, polypharmacy, home hazards, and chronic medical conditions such as arthritis, osteoporosis, and stroke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are some recommended strategies for preventing falls in older adults?

A

Some recommended strategies for preventing falls in older adults include exercise programs to improve strength, balance and mobility, medication review and management, vision assessment and correction, home safety assessment and modification, and management of chronic medical conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How can home hazards be addressed to prevent falls?

A

Home hazards can be addressed by conducting a home safety assessment, which may involve identifying and removing tripping hazards, improving lighting and visibility, installing handrails and grab bars, and using non-slip surfaces and footwear. Simple modifications such as removing clutter, securing loose rugs, and keeping commonly used items within reach can also help reduce the risk of falls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Who is considered high-risk for falls under the RACGP guidelines

A

According to the RACGP Red Book guidelines, the following individuals are considered to be at high risk of falls:

  1. Older adults aged 65 years and older, particularly those who have experienced a fall in the past year
  2. Individuals with medical conditions that affect balance, mobility, or cognitive function, such as Parkinson’s disease, stroke, dementia, or peripheral neuropathy
  3. Individuals taking multiple medications, especially those with sedative, hypnotic, or psychotropic effects
  4. Individuals with visual impairment, particularly those with decreased contrast sensitivity, depth perception, or visual acuity
  5. Individuals living in environments with hazards that increase the risk of falls, such as uneven surfaces, cluttered spaces, or inadequate lighting.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the key risk factors for dementia?

A

The key risk factors for dementia include age, genetics, cardiovascular risk factors (such as hypertension, diabetes, and hyperlipidemia), head injury, and low educational attainment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What are the recommended screening tools for cognitive impairment in primary care?

A

The recommended screening tools for cognitive impairment in primary care include the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Screening questions for dementia.

A

Have you noticed any changes in your memory or thinking abilities?

Have you experienced any difficulty with daily tasks, such as cooking, cleaning, or managing finances?

Have you noticed any changes in your mood or behavior, such as becoming more irritable, anxious, or depressed?

Have you had any recent falls or accidents?

Have you noticed any changes in your sense of direction or ability to navigate familiar places?

Have family members or friends expressed concern about your memory or thinking abilities?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Hep B Vaccination Guidelines.

A

Infants: The first dose of the hepatitis B vaccine is recommended within the first 24 hours of life, followed by two more doses at 2 and 6 months of age.

Unvaccinated adults: two adult doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

HPV Vaccination Guidelines

A

Routine HPV vaccination for adolescents: The HPV vaccine is recommended for routine use in both boys and girls at age 12-13 years. The vaccine is given as a 2-dose series with a 6- to 12-month interval between doses. Adolescents who start the vaccine series at age 14 years or older require a 3-dose series.

Catch-up HPV vaccination for older adolescents and young adults: HPV vaccine catch-up programs are available for individuals who missed getting vaccinated during the routine vaccination period. For individuals aged 14-19 years, a 2-dose series with a 6- to 12-month interval between doses is recommended. For individuals aged 20-26 years, a 3-dose series is recommended.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

MMR Vaccination Guidelines

A

Routine MMR vaccination for children: The MMR vaccine is recommended for routine use in children at 12 months of age. A second dose is recommended at 18 months of age or older, typically given at 4 years of age.

Catch-up MMR vaccination for older children and adults: MMR vaccine catch-up programs are available for individuals who missed getting vaccinated during the routine vaccination period. Individuals born during or after 1966 who have not had two documented doses of MMR vaccine, or who do not have evidence of immunity to measles, mumps, and rubella, should receive the MMR vaccine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

DTPa Guidelines

A

Routine DTPa vaccination for children: The DTPa vaccine is recommended for routine use in children at 2, 4, and 6 months of age, with booster doses at 18 months and 4 years of age.

Catch-up DTPa vaccination for older children and adults: DTPa vaccine catch-up programs are available for individuals who missed getting vaccinated during the routine vaccination period. Individuals who have not completed the primary DTPa vaccination series or who have not received a booster dose in the past 10 years should receive the vaccine.

46
Q

dTpa Guidelines:

A

Routine dTpa vaccination for adolescents: A single dose of dTpa vaccine is recommended for all adolescents at 14 to 16 years of age, as part of the National Immunisation Program (NIP) schedule.

Routine dTpa vaccination for adults: Adults who have not received a dTpa booster dose in the past 10 years should receive a single dose of dTpa vaccine. This is recommended for all adults aged 50 years and over, and for some occupational groups such as healthcare workers.

47
Q

Vaccinations that are recommended but not funded under the NIP.

A

Meningococcal B vaccine: This vaccine is recommended for individuals at increased risk of meningococcal disease, including infants and young children, adolescents, and individuals with certain medical conditions.

Meningococcal ACWY vaccine: This vaccine is recommended for individuals at increased risk of meningococcal disease, including adolescents and young adults, and individuals with certain medical conditions.

Pneumococcal vaccine: This vaccine is recommended for adults aged 65 years and over, and individuals with certain medical conditions.

Varicella (chickenpox) vaccine: This vaccine is recommended for individuals who have not had chickenpox and are at increased risk of infection, including healthcare workers, pregnant women, and individuals with certain medical conditions.

Hepatitis A vaccine: This vaccine is recommended for individuals at increased risk of hepatitis A infection, including travelers to areas with high rates of infection, men who have sex with men, and individuals with certain medical conditions.

Hepatitis B vaccine: This vaccine is recommended for individuals at increased risk of hepatitis B infection, including healthcare workers, individuals with certain medical conditions, and individuals who engage in high-risk behaviors.

Human papillomavirus (HPV) vaccine: This vaccine is recommended for females and males aged 12 to 13 years as part of the routine vaccination program, but is not funded for older age groups.

48
Q

How often should individuals at increased risk of STIs undergo screening according to the RACGP guidelines?

A

Individuals at increased risk of STIs should undergo screening at least annually according to the RACGP guidelines.

Increased-risk individuals include people who inject drugs, sex workers, FN people, men who have sex with men, or those who have unprotected anal sex or multiple sex partners.

49
Q

What are the recommended STI screening tests for pregnant women according to the RACGP guidelines?

A

The recommended STI screening tests for pregnant women according to the RACGP guidelines include chlamydia, gonorrhea, syphilis, and HIV.

50
Q

What are the general follow-up measures for individuals who test positive for STIs according to the RACGP guidelines?

A

The appropriate follow-up measures for individuals who test positive for STIs according to the RACGP guidelines include treatment with antibiotics or antiviral medications, partner notification and treatment, retesting after treatment, and counseling on safe sex practices.

51
Q

What is the appropriate timing for STI screening after exposure to a high-risk sexual partner?

A

The appropriate timing for STI screening after exposure to a high-risk sexual partner is 2-3 weeks after exposure for chlamydia and gonorrhea, and 4-6 weeks after exposure for syphilis and HIV, according to the RACGP guidelines.

52
Q

STI Screening Recommendations for men who have sex with men.

A

Chlamydia and gonorrhea: MSM should be screened for chlamydia and gonorrhea annually at a minimum, or more frequently if they have multiple sexual partners or engage in high-risk sexual behaviors.

Syphilis: MSM should be screened for syphilis annually, or more frequently if they have multiple sexual partners or engage in high-risk sexual behaviors.

HIV: MSM should be offered a HIV test at least once a year, or more frequently if they have multiple sexual partners or engage in high-risk sexual behaviors.

Hepatitis B: MSM should be vaccinated against hepatitis B, and those who are not vaccinated should be offered testing for hepatitis B at least once in their lifetime.

Hepatitis C: MSM should be offered a hepatitis C test at least once in their lifetime, and more frequently if they engage in high-risk behaviors such as injection drug use or sharing of sex toys.

53
Q

How often CVD absolute risk should be done based on the RACGP guidelines?

A

According to the RACGP guidelines, CVD absolute risk assessment should be done at least every 2 years for individuals aged 45-74 years (or from 35 years for FN people), and more frequently if there are significant changes in the person’s risk factors or health status.

54
Q

Which groups of individuals do not require absolute CVD risk assessment?

A
  1. <45 years with no known risk factors for CVD
  2. Known history of CVD, including heart attack, stroke, or angina
  3. > 60 years old and have diabetes
  4. Have chronic kidney disease (eGFR<45)
  5. Diagnosis of familial hypercholesterolaemia
  6. SBP ≥160 mmHg or DBP≥110 mmHg
  7. Total cholesterol consistently ≥7.5 mmol/L
  8. Diagnosis of atrial fibrillation
55
Q

What is the BP target based on the RACGP guidelines?

A

For patients without diabetes or target organ damage: BP < 140/90 mmHg
For patients with diabetes, kidney disease or target organ damage: BP < 130/80 mmHg

56
Q

What are the lipid level targets based on the RACGP guidelines?

A

Total cholesterol: < 4.0 mmol/L (high risk) ; 5.5 mmol/L (general)
LDL-cholesterol: < 1.8 mmol/L (high risk) ; 2.0 mmol/L (general)
HDL-cholesterol: > 1.0 mmol/L
Triglycerides: < 2.0 mmol/L

57
Q

When would you start someone on antihypertensive based on the RACGP guidelines?

A

<10% CVD risk: if BP>160/110mmHg

10-15% CVD risk: if SBP>140mmHg and/or DBP>90mmHg

> 15% CVD risk or clinically determined high risk: commence antihypertensive along with lipid therapy

58
Q

When would you start someone on lipid-lowering medications based on the RACGP guidelines?

A
  1. Established CVD, regardless of lipid levels
  2. Primary hypercholesterolaemia with an LDL-C ≥4.0 mmol/L
  3. A high absolute CVD risk (≥15% risk of a CVD event over the next 5 years) and an LDL level ≥2.0 mmol/L
  4. Diabetes with an LDL-C ≥2.0 mmol/L, or an LDL-C ≥1.8 mmol/L in the presence of additional risk factors such as albuminuria or smoking
  5. Intermediate absolute CVD risk (10-15% risk of a CVD event over the next 5 years) and an LDL-C level ≥3.5 mmol/L, particularly if they have additional risk factors such as smoking or a family history of premature CVD.
59
Q

What factors are considered in AUSDRISK?

A

AUSDRISK (Australian Type 2 Diabetes Risk Assessment Tool) is a risk assessment tool used to identify individuals at high risk of developing type 2 diabetes. The tool includes the following factors:

Age
Gender
Country of birth
Family history of diabetes
History of high blood glucose
Physical activity levels
Fruit and vegetable intake
Smoking status
Alcohol consumption
High blood pressure
Waist circumference/BMI

60
Q

What are the risk factors for developing type 2 diabetes?

A

Risk factors for type 2 diabetes include obesity, physical inactivity, family history of diabetes, high blood pressure, high cholesterol, and smoking.

61
Q

What is the recommended screening frequency for type 2 diabetes?

A

The recommended screening frequency for type 2 diabetes is every three years for people aged 40-49 years, and every one to two years for people aged 50 years and older, or those with additional risk factors.

62
Q

Which individuals are considered at high risk of developing T2D based on the RACGP guidelines?

A

According to the RACGP guidelines, the following individuals are considered at high risk of developing type 2 diabetes:

  • Age over 40 years and being overweight or obese
  • AUSDRISK>12 points
  • Family history of T2D
  • History of gestational diabetes or polycystic ovary syndrome
  • High blood pressure, high cholesterol or other lipid disorders, or cardiovascular disease
  • History of impaired glucose tolerance or impaired fasting glucose
  • On antipsychotics
  • High-risk population group, including Aboriginal and Torres Strait Islander peoples, Pacific Islanders, and individuals from South Asian, Middle Eastern, or North African backgrounds.
63
Q

What are the tests to diagnose diabetes and their values?

A

Fasting plasma glucose (FPG): A person is diagnosed with diabetes if their FPG level is equal to or greater than 7.0 mmol/L after an overnight fast of at least 8 hours.

2-hour oral glucose tolerance test (OGTT): A person is diagnosed with diabetes if their glucose level is equal to or greater than 11.1 mmol/L two hours after ingesting a 75g glucose load.

HbA1c: A person is diagnosed with diabetes if their HbA1c level is equal to or greater than 6.5%.

64
Q

The various value of fasting blood glucose results and their indications.

A

<5.5 mmol/L: diabetes unlikely
5.5-6.9 mmol/L: may need to perform OGTT (impaired glucose tolerance)
>7 mmol/L: diabetes likely

65
Q

What is the screening protocol for CKD?

A
  1. Determine the patient’s risk factors for CKD, including age, family history, hypertension, diabetes, cardiovascular disease, smoking, obesity, and a history of kidney disease or kidney injury.
  2. Check for BP, urine ACR, and eGFR.
  3. If ACR is positive, arrange two further samples within next 3 months (preferably first morning void)
  4. if eGFR<60, repeat within 7 days

Acute reduction of eGFR => possible AKI

Stable reduced eGFR +/- elevated urine ACR => CKD staging

66
Q

What are the stages of kidney function based on eGFR?

A

Stage 1: Kidney damage with normal or high eGFR (90 or above)
Stage 2: Kidney damage with mildly decreased eGFR (60 to 89)
Stage 3: Moderately decreased eGFR (30 to 59)
Stage 4: Severely decreased eGFR (15 to 29)
Stage 5: Kidney failure (eGFR less than 15 or dialysis)

It’s important to note that kidney disease can also be classified based on the presence of albuminuria (excess protein in urine).

67
Q

What are the different categories of urine ACR for male and female?

A

The categories for males are:

Normal: ACR < 2.5 mg/mmol
Microalbuminuria: ACR 2.5-25 mg/mmol
Macroalbuminuria: ACR > 25 mg/mmol

The categories for females are:

Normal: ACR < 3.5 mg/mmol
Microalbuminuria: ACR 3.5-35 mg/mmol
Macroalbuminuria: ACR > 35 mg/mmol

68
Q

Who is at high risk of developing prostate cancer?

A

Men with a family history of prostate cancer (diagnosed <65yo)
Men with a family history of breast cancer (BRCA1/2 gene)

69
Q

What are the screening recommendations for prostate cancer?

A

The RACGP does not recommend routine prostate-specific antigen (PSA) screening for prostate cancer. Instead, they recommend individualized decision-making, taking into account a patient’s risk factors and values.

70
Q

What are the symptoms of prostate cancer?

A

Early-stage prostate cancer usually has no symptoms.

Symptoms may include difficulty urinating, frequent urination (especially at night), blood in the urine or semen, pain during ejaculation, and pain or stiffness in the lower back, hips, or thighs.

71
Q

How is prostate cancer diagnosed?

A

Prostate cancer can be diagnosed using a combination of PSA blood test, digital rectal examination (DRE), and prostate biopsy.

A biopsy is required to confirm the presence of cancer.

72
Q

What are the side effects of treatment for prostate cancer?

A

Treatment for prostate cancer can have side effects, including urinary incontinence, erectile dysfunction, and bowel problems.

The severity and duration of side effects depend on the type of treatment and the individual patient.

73
Q

What are normal PSA values?

A

Normal PSA (Prostate-Specific Antigen) values can vary depending on age, with the average values increasing as men get older. According to the RACGP guidelines, normal PSA values for men aged 50-69 years old are typically less than 3 ng/mL. However, it’s important to note that PSA values can also be affected by factors such as prostate size, medication use, and recent sexual activity, and that PSA testing should be interpreted in the context of other clinical factors.

74
Q

What can potentially alter PSA values?

A

Prostate cancer: PSA levels are generally higher in men with prostate cancer.

Benign prostatic hyperplasia (BPH): BPH is a non-cancerous enlargement of the prostate gland that can cause an increase in PSA levels.

Prostatitis: Prostatitis is inflammation of the prostate gland and can cause elevated PSA levels.

Recent ejaculation: PSA levels may be elevated for a short time after ejaculation.

Certain medications: Certain medications, such as finasteride and dutasteride, which are used to treat BPH, can cause a decrease in PSA levels. However, if prostate cancer is present, these medications may make it harder to detect by lowering PSA levels.

75
Q

What are the screening recommendations for average-risk individuals for colorectal cancer?

A

The screening recommendations for average-risk individuals for colorectal cancer include a fecal occult blood test (FOBT) every 2 years from the age of 50 years.

76
Q

What are the screening recommendations for moderate-risk individuals for colorectal cancer?

A

The screening recommendation for high-risk individuals is a colonoscopy every 5 years, from the age of 50 or 10 years younger than the age of the first diagnosis of CRC in the family.

Consider doing FOBT in the intervening years.

77
Q

Which group is considered low risk for CRC?

A

Individuals with no personal history of bowel cancer, colorectal adenomas, IBD, or family history of CRC.

Or has a family history of CRC, but the age of diagnosis >55yo.

78
Q

Which group is considered moderate risk for CRC?

A

Asymptomatic individuals with family history of CRC diagnosed <55yo.

79
Q

What are the symptoms of colorectal cancer?

A

The symptoms of colorectal cancer can include changes in bowel habits, blood in the stool, abdominal pain, unexplained weight loss, and fatigue.

80
Q

What are the screening recommendations for breast cancer?

A

The RACGP recommends that women aged 50-74 years have a mammogram every two years. Women aged 40-49 years can also have mammograms, but the frequency and timing of screening should be based on individual risk assessment. Women over 75 years of age should discuss the benefits and risks of continued screening with their doctor.

81
Q

How is breast cancer diagnosed?

A

Breast cancer can be diagnosed through a combination of physical examination, imaging tests (such as mammogram, ultrasound, or MRI), and biopsy (removal of a small amount of tissue for examination under a microscope).

82
Q

What are the screening recommendations for skin cancer?

A

Self-examination: Individuals should be advised to perform regular self-examinations of their skin, looking for any changes in the size, shape, color, or texture of existing moles or the appearance of new ones.

Professional skin examination: Clinicians should perform a full skin examination on patients who present with symptoms or risk factors, and those who request a skin check. This should include examining all areas of the skin, including the scalp, soles of the feet, and between the fingers and toes.

High-risk groups: Patients with a personal or family history of skin cancer, fair skin, a history of severe sunburn, immunosuppression, or a high number of moles should be considered at high risk and may require more frequent skin examinations.

Imaging techniques: In certain cases, imaging techniques such as dermoscopy or total body photography may be used to aid in the detection of skin cancer.

Education and prevention: Patients should be educated about the importance of sun protection, including wearing protective clothing, hats, and sunglasses, seeking shade, and applying sunscreen regularly.

83
Q

What are the screening recommendations for cervical cancer?

A

Cervical screening should start at age 25 years for people who have a cervix or two years after having sexual intercourse.

Women aged 25-74 years who have ever been sexually active should have a Cervical Screening Test (CST) every five years.

Women aged 70-74 years who have had regular screening in the previous 10 years should have an exit CST. If they have not had regular screening in the previous 10 years, they should be screened two years after their last Pap test.

84
Q

What are the screening recommendations for osteoporosis?

A

All women aged 70 years and older should be screened for osteoporosis.

Women aged 50–69 years who have risk factors for osteoporosis should also be considered for screening.

Men aged 70 years and older who have risk factors for osteoporosis should be considered for screening.

Individuals aged 50 years and older who have sustained a low-trauma fracture should be assessed for osteoporosis.

Bone density testing is recommended for all individuals who have sustained a fragility fracture, regardless of age.

Individuals taking long-term glucocorticoid therapy should be considered for bone density testing.

Individuals with other conditions associated with osteoporosis (e.g. hyperparathyroidism, malabsorption syndromes) should also be considered for bone density testing.

85
Q

What is shown here?

A

Cholesteatoma

Otoscopic image of the left tympanic membrane.

Encrustation and darkening of the epithelium can be seen in the posterior upper quadrant marginal to the pars flaccida (arrow). The localization and findings indicate a cholesteatoma.

86
Q
A

Atopic dermatitis, also called atopic eczema, the most common inflammatory skin disease worldwide, presents as generalised skin dryness, itch, and rash.

87
Q
A

Chronic plaque psoriasis

Large, well-demarcated, red, scaly and thickened areas of skin. It is most likely to affect elbows, knees, and lower back but may arise on any part of the body.

88
Q
A

Multiple small scaly erythematous lesions are visible.

This appearance is typical of guttate psoriasis and is most often precipitated by group A streptococcal infection.

89
Q
A

A scaly, erythematous plaque surrounded by multiple, partly confluent, follicular papules is visible on the skin of the antecubital fossa. Features include lichenification, dry skin, scaling, fissuring, post-inflammatory hyp/hyper pigmentation

This finding is characteristic of chronic eczema

90
Q
A

Nail pitting in psoriasis

Multiple, small round depressions are seen in the nails.

91
Q
A

Nail pitting and onycholysis are typical features of psoriasis with nail involvement.

92
Q

What is the deepest level of skin that warts grow down into?

Epidermis/Dermis/Subcutaneous tissue

A

Epidermis

93
Q
A

Molluscum contagiosum is a common poxvirus skin infection of childhood that causes localised clusters of umbilicated epidermal papules.

94
Q

This rash on a young adult appeared 2 days after starting amoxicillin for a sore throat . What is the most likely cause of their sore throat ? ​

A

The typical exanthem of infectious mononucleosis is an acute, generalised maculopapular rash.

A more intense and extensive cutaneous eruption appears in up to 90% of patients with infectious mononucleosis 2–10 days after starting antibiotics. The rash usually resolves within a week of discontinuing the antibiotic.

95
Q
A

This is pityriasis versicolor. It is a benign infection of the skin common in hot/humid climates. Flaky discoloured patches appear on the chest and back.

Pityriasis versicolor is caused by mycelial growth of fungi of the genus Malassezia.

96
Q
A

An asymmetric nodule (~1 cm in diameter) with central ulceration, and rolled out edges.

This appearance is typical of nodular basal cell carcinoma.

97
Q
A

Basal cell carcinoma

A pearly nodule with central atrophy and peripheral telangiectatic vessels is visible on the front of the nose.

98
Q
A

flat, eczematous (scaly) plaque with a pearly border with multiple microerosions.

A plaque with raised borders and crusting is the typical appearance of superficial basal cell carcinoma

99
Q
A

Seborrhoeic keratosis

Multiple darkly pigmented papules/plaques, sharply demarcated, and soft
Greasy, wax-like, and “stuck-on” appearance

100
Q
A

Seborrhoeic keratosis

101
Q
A

Actinic keratosis

The entire hairless portion of the scalp is covered with telangiectasia, light brown papules, and yellow-brownish, hyperkeratotic plaques.

102
Q
A

Actinic keratosis

Multiple scaly lesions on erythematous skin are visible.

103
Q
A

Cutaneous SCC

104
Q
A

SCC

105
Q
A

Malignant melanoma

A hyperpigmented, slow-growing lesion can be seen on the medial border of the sole. The lesion is asymmetric, has an irregular border and variable pigmentation, and is ∼8 mm in diameter.

This lesion fulfills the A (asymmetry), B (border irregularity), C (color variegation), D (diameter >6 mm), and E (evolving lesion; increase in size) criteria for diagnosing malignant melanoma. The diagnosis should be confirmed by performing a full-thickness biopsy of the lesion.

106
Q
A

Lentigo maligna

A 3-cm large, irregularly pigmented macule with irregular borders and surrounding mottling is visible.

This appearance is suggestive of lentigo maligna. However, dermoscopy should be performed to further assess and classify the lesion.

107
Q
A

Healthy tympanic membrane

108
Q
A

Acute otitis media:

Note inflammation, bulging of TM and loss of anatomical landmarks

109
Q
A

Eczema herpeticum

A vesicular eruption with multiple monomorphic, circular, partially confluent lesions, many of which show central umbilication is seen on the right shoulder of a patient with atopic dermatitis.

Eczema herpeticum is considered a dermatological emergency and treatment with oral or IV acyclovir must be initiated quickly.

110
Q
A

Erythema multiforme

Target (bull’s-eye) lesions are located on the lower right arm and hand. The lesions consist of three layers: a blue livid center, pale intermediate zone, and a dark red peripheral rim. Some exhibit central blistering.

111
Q
A

Herpes Zoster

112
Q

Recommended vaccine during pregnancy

A

Influenza, at anytime during pregnancy

Pertussis, 20-32 weeks